Respiratory Medicine
Volume 104, Issue 4 , Pages 571-577 , April 2010

Deficiency of pulmonary Vα24 Vβ11 natural killer T cells in corticosteroid-naïve sarcoidosis patients

Received 17 June 2009 ,Accepted 15 November 2009.

References 

  1. Agostini C, Meneghin A, Semenzato G. T-lymphocytes and cytokines in sarcoidosis. Curr Opin Pulm Med. 2002 Sep;8(5):435–440
  2. Ho LP, Urban BC, Thickett DR, Davies RJ, McMichael AJ. Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis. Lancet. 2005 Mar 19–25;365(9464):1062–1072
  3. Norris S, Doherty DG, Collins C, McEntee G, Traynor O, Hegarty JE, et al. Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells. Hum Immunol. 1999 Jan;60(1):20–31
  4. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol. 2002 Aug;2(8):557–568
  5. Matsuda JL, Gapin L, Fazilleau N, Warren K, Naidenko OV, Kronenberg M. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size. Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12636–12641
  6. Wajchman HJ, Pierce CW, Varma VA, Issa MM, Petros J, Dombrowski KE. Ex vivo expansion of CD8+ CD56+ and CD8+ CD56-natural killer T cells specific for MUC1 mucin. Cancer Res. 2004 Feb 1;64(3):1171–1180
  7. Korosec P, Osolnik K, Kern I, Silar M, Mohorcic K, Kosnik M. Expansion of pulmonary CD8+ CD56+ natural killer T-cells in hypersensitivity pneumonitis. Chest. 2007 Oct;132(4):1291–1297
  8. Kadowaki N, Antonenko S, Ho S, Rissoan MC, Soumelis V, Porcelli SA, et al. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med. 2001;193:1221–1226
  9. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol. 2003;4:1230–1237
  10. Crowe NY, Coquet JM, Berzins SP, Kyparissoudis K, Keating R, Pellicci DG, et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J Exp Med. 2005;202:1279–1288
  11. Shimizu K, Goto A, Fukui M, Taniguchi M, Fujii S. Tumor cells loaded with _-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice. J Immunol. 2007;178:2853–2861
  12. Sonoda KH, Exley M, Snapper S, Balk SP, Stein-Streilein J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med. 1999;190:1215–1226
  13. Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, et al Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat Med. 2001;7:1057–1062
  14. Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, et al The natural killer T-cell ligand-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med. 2001;7:1052–1056
  15. Miyamoto K, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature. 2001;413:531–534
  16. Jahng AW, Maricic I, Pedersen B, Burdin N, Naidenko O, Kronenberg M, et al. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med. 2001;194:1789–1799
  17. Kaieda S, Tomi C, Oki S, Yamamura T, Miyake S. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody induced arthritis. Arthritis Rheum. 2007;56:1836–1845
  18. ATS/ERS/WASOG Committee . Statement on sarcoidosis. Am J Respir Crit Care Med. 1999;160:736–755
  19. Scadding JG. Prognosis of intrathoracic sarcoidosis in England. Br Med J. 1961;4:1165–1172
  20. Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M, et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med. 2006 Mar 16;354(11):1117–1129
  21. Vijayanand P, Seumois G, Pickard C, Powell RM, Angco G, Sammut D, et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med. 2007 Apr 5;356(14):1410–1422
  22. Thomas SY, Lilly CM, Luster AD. Invariant natural killer T cells in bronchial asthma. N Engl J Med. 2006 Jun 15;354(24):2613–2616
  23. Mempel M, Flageul B, Suarez F, Ronet C, Dubertret L, Kourilsky P, et al. Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas. Presence of Valpha24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Valpha repertoire. Am J Pathol. 2000 Aug;157(2):509–523
  24. Kobayashi S, Kaneko Y, Seino K, Yamada Y, Motohashi S, Koike J, et al. Impaired IFN-gamma production of Valpha24 NKT cells in non-remitting sarcoidosis. Int Immunol. 2004 Feb;16(2):215–222
  25. Roberts SD, Kohli LL, Wood KL, Wilkes DS, Knox KS. CD4+ CD28-T cells are expanded in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2005 Mar;22(1):13–19
  26. Grunewald J, Wahlström J, Berlin M, Wigzell H, Eklund A, Olerup O. Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation. Thorax. 2002 Apr;57(4):348–352
  27. Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature. 1998 Jan 8;391(6663):177–181
  28. Baughman RP, Lower EE. Treatment of sarcoidosis with corticosteroids: who is going to relapse and why?. Sarcoidosis Vasc Diffuse Lung Dis. 1998 Mar;15(1):19–20
  29. Katchar K, Soderstrom K, Wahlstrom J, Eklund A, Grunewald J. Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients. Eur Respir J. 2005 Jul;26(1):77–85
  30. Papakosta D, Kyriazis G, Gioulekas D, Kontakiotis T, Polyzoni T, Bouros D, et al. Variations in alveolar cell populations, lymphocyte subsets and NK-cells in different stages of active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2005 Mar;22(1):21–26
  31. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med. 2003 May;9(5):582–588
  32. Mutalithas K, Croudace J, Guillen C, Siddiqui S, Thickett D, Wardlaw A, et al. Bronchoalveolar lavage invariant natural killer T cells are not increased in asthma. J Allergy Clin Immunol. 2007 May;119(5):1274–1276
  33. Matangkasombut P, Marigowda G, Ervine A, Idris L, Pichavant M, Kim HY, et al. Natural killer T cells in the lungs of patients with asthma. J Allergy Clin Immunol. 2009 May;123(5):1181–1185
  34. Baev DV, Caielli S, Ronchi F, Coccia M, Facciotti F, Nichols KE, et al. Impaired SLAM–SLAM homotypic interaction between invariant NKT cells and dendritic cells affects differentiation of IL-4/IL-10-secreting NKT2 cells in nonobese diabetic mice. J Immunol. 2008 Jul 15;181(2):869–877
  35. Jordan MA, Fletcher JM, Pellicci D, Baxter AG. Slamf1, the NKT cell control gene Nkt1. J Immunol. 2007;178:1618–1627
  36. Cantorna MT, Yu S, Bruce D. The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5207–5212
  37. Niimi T, Tomita H, Sato S, Kawaguchi H, Akita K, Maeda H, et al. Vitamin D receptor gene polymorphism in patients with sarcoidosis. Am J Respir Crit Care Med. 1999 Oct;160(4):1107–1109

PII: S0954-6111(09)00372-2

doi: 10.1016/j.rmed.2009.11.008

Respiratory Medicine
Volume 104, Issue 4 , Pages 571-577 , April 2010

Article Tools

* Image Usage & Resolution